We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.1B
AUM Growth
+$537M
Cap. Flow
+$109M
Cap. Flow %
1.79%
Top 10 Hldgs %
28.24%
Holding
390
New
23
Increased
194
Reduced
115
Closed
7

Top Buys

Rank Stock Value
1
WEC icon
WEC Energy
WEC
+$48.4M
2
MRK icon
Merck
MRK
+$30.1M
3
GE icon
GE Aerospace
GE
+$27.7M
4
TWX
Time Warner Inc
TWX
+$24.2M
5
SE
Spectra Energy Corp Wi
SE
+$23.5M

Top Sells

Rank Stock Value
1
KMI icon
Kinder Morgan
KMI
+$46M
2
SO icon
Southern Company
SO
+$43.7M
3
IBM icon
IBM
IBM
+$32.6M
4
ADP icon
Automatic Data Processing
ADP
+$21.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$19.8M

Sector Composition

Rank Sector Weight
1 Technology 15.65%
2 Healthcare 15.49%
3 Consumer Staples 15.31%
4 Industrials 11.41%
5 Energy 11.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEA icon
326
Vanguard FTSE Developed Markets ETF
VEA
$234B
$283K ﹤0.01%
6,795
BRFS
327
DELISTED
BRF SA
BRFS
$280K ﹤0.01%
13,430
-400
-3% -$9.19K
FSP
328
Franklin Street Properties
FSP
$48M
$279K ﹤0.01%
23,363
MATW icon
329
Matthews International
MATW
$857M
$279K ﹤0.01%
6,555
+495
+8% +$20.2K
AAN.A
330
DELISTED
The Aaron's Company Inc Class A
AAN.A
$275K ﹤0.01%
9,363
+710
+8% +$20.9K
LWAY icon
331
Lifeway Foods
LWAY
$449M
$270K ﹤0.01%
16,875
+1,420
+9% +$21K
AFL icon
332
Aflac
AFL
$63.9B
$268K ﹤0.01%
8,016
FLS icon
333
Flowserve
FLS
$10.1B
$266K ﹤0.01%
3,378
+1
+0% +$69
RIO icon
334
Rio Tinto
RIO
$165B
$262K ﹤0.01%
4,640
+140
+3% +$7.28K
NXGN
335
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$256K ﹤0.01%
12,153
+865
+8% +$19.5K
SNN icon
336
Smith & Nephew
SNN
$12.7B
$253K ﹤0.01%
8,830
+487
+6% +$12.8K
PHO icon
337
Invesco Water Resources ETF
PHO
$2.08B
$250K ﹤0.01%
9,520
+120
+1% +$2.97K
FCX icon
338
Freeport-McMoran
FCX
$99.8B
$249K ﹤0.01%
6,600
BEN icon
339
Franklin Resources
BEN
$17.7B
$245K ﹤0.01%
4,245
+45
+1% +$2.43K
AGN
340
DELISTED
Allergan Inc
AGN
$242K ﹤0.01%
+2,182
New +$208K
FMS icon
341
Fresenius Medical Care
FMS
$12.8B
$235K ﹤0.01%
6,600
-132
-2% -$4.43K
VYM icon
342
Vanguard High Dividend Yield ETF
VYM
$82.5B
$234K ﹤0.01%
+3,757
New +$227K
JWN
343
DELISTED
Nordstrom
JWN
$232K ﹤0.01%
3,752
UN
344
DELISTED
Unilever NV New York Registry Shares
UN
$231K ﹤0.01%
5,751
+151
+3% +$5.88K
VTI icon
345
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$229K ﹤0.01%
2,384
SRCL
346
DELISTED
Stericycle Inc
SRCL
$229K ﹤0.01%
1,970
-130
-6% -$15.2K
HIW icon
347
Highwoods Properties
HIW
$3.58B
$228K ﹤0.01%
6,300
-67
-1% -$2.44K
TESS
348
DELISTED
Tessco Technologies Inc
TESS
$228K ﹤0.01%
+5,655
New +$212K
UPS icon
349
United Parcel Service
UPS
$91.5B
$226K ﹤0.01%
+2,147
New +$211K
CLD
350
DELISTED
Cloud Peak Energy Inc
CLD
$225K ﹤0.01%
12,500

Similar funds

Bahl & Gaynor's Q4 2013 Portfolio in Review

As of Q4 2013, Bahl & Gaynor held 390 positions worth $6.1B, up 9.7% from $5.56B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bahl & Gaynor's Q4 2013 filing shows 23 new, 194 increased, 115 reduced and 7 closed positions. Its largest new stake was Time Warner Inc: 373,972 shares worth $25M. The largest sale was Kinder Morgan, an estimated $46M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Bahl & Gaynor's largest Q4 2013 buy was Time Warner Inc: 373,972 shares worth $25M.
  • Bahl & Gaynor added most to WEC Energy in Q4 2013, an estimated $48.4M increase.
  • Bahl & Gaynor's biggest Q4 2013 reduction was Kinder Morgan, cutting an estimated $46M.
  • Bahl & Gaynor fully exited QUESTCOR PHARMA INC in Q4 2013, selling an estimated $499K.
  • Bahl & Gaynor's ten largest holdings make up 28% of its $6.1B portfolio in Q4 2013.
  • Bahl & Gaynor opened 23 new positions and closed 7 in Q4 2013.
  • Bahl & Gaynor's portfolio value rose 9.7% quarter-over-quarter to $6.1B.

Based on Bahl & Gaynor's 13F filing for Q4 2013, filed 14 Feb 2014.